These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Gbetagamma signaling and Ca2+ mobilization co-operate synergistically in a Sos and Rac-dependent manner in the activation of JNK by Gq-coupled receptors. Chan AS; Wong YH Cell Signal; 2004 Jul; 16(7):823-36. PubMed ID: 15115661 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of 14-3-3 binding to Rictor of mTORC2 for Akt phosphorylation at Ser473 is regulated by selenoprotein W. Jeon YH; Park YH; Kwon JH; Lee JH; Kim IY Biochim Biophys Acta; 2013 Oct; 1833(10):2135-42. PubMed ID: 23680186 [TBL] [Abstract][Full Text] [Related]
7. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK. Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225 [TBL] [Abstract][Full Text] [Related]
8. IKK interacts with rictor and regulates mTORC2. Xu Y; Lai E; Liu J; Lin J; Yang C; Jia C; Li Y; Bai X; Li M Cell Signal; 2013 Nov; 25(11):2239-45. PubMed ID: 23872070 [TBL] [Abstract][Full Text] [Related]
10. A Positive Feedback Loop between Akt and mTORC2 via SIN1 Phosphorylation. Yang G; Murashige DS; Humphrey SJ; James DE Cell Rep; 2015 Aug; 12(6):937-43. PubMed ID: 26235620 [TBL] [Abstract][Full Text] [Related]
11. Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML. Zeng Z; Sarbassov dos D; Samudio IJ; Yee KW; Munsell MF; Ellen Jackson C; Giles FJ; Sabatini DM; Andreeff M; Konopleva M Blood; 2007 Apr; 109(8):3509-12. PubMed ID: 17179228 [TBL] [Abstract][Full Text] [Related]
12. Signal transduction pathways in FSH regulation of rat Sertoli cell proliferation. Riera MF; Regueira M; Galardo MN; Pellizzari EH; Meroni SB; Cigorraga SB Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E914-23. PubMed ID: 22275758 [TBL] [Abstract][Full Text] [Related]
13. Fisetin regulates obesity by targeting mTORC1 signaling. Jung CH; Kim H; Ahn J; Jeon TI; Lee DH; Ha TY J Nutr Biochem; 2013 Aug; 24(8):1547-54. PubMed ID: 23517912 [TBL] [Abstract][Full Text] [Related]
14. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway. Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912 [TBL] [Abstract][Full Text] [Related]
15. Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development. Burchert A; Wang Y; Cai D; von Bubnoff N; Paschka P; Müller-Brüsselbach S; Ottmann OG; Duyster J; Hochhaus A; Neubauer A Leukemia; 2005 Oct; 19(10):1774-82. PubMed ID: 16136169 [TBL] [Abstract][Full Text] [Related]
16. A docking site for G protein βγ subunits on the parathyroid hormone 1 receptor supports signaling through multiple pathways. Mahon MJ; Bonacci TM; Divieti P; Smrcka AV Mol Endocrinol; 2006 Jan; 20(1):136-46. PubMed ID: 16099817 [TBL] [Abstract][Full Text] [Related]
17. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma. Peponi E; Drakos E; Reyes G; Leventaki V; Rassidakis GZ; Medeiros LJ Am J Pathol; 2006 Dec; 169(6):2171-80. PubMed ID: 17148679 [TBL] [Abstract][Full Text] [Related]
18. mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR. Yin Y; Hua H; Li M; Liu S; Kong Q; Shao T; Wang J; Luo Y; Wang Q; Luo T; Jiang Y Cell Res; 2016 Jan; 26(1):46-65. PubMed ID: 26584640 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease. Chen S; Nakahara T; Uchi H; Takeuchi S; Takahara M; Kido M; Dugu L; Tu Y; Moroi Y; Furue M Br J Dermatol; 2009 Aug; 161(2):357-63. PubMed ID: 19438435 [TBL] [Abstract][Full Text] [Related]
20. Involvement of PI3K-AKT-mTOR pathway in protein kinase CKII inhibition-mediated senescence in human colon cancer cells. Park JH; Kim JJ; Bae YS Biochem Biophys Res Commun; 2013 Apr; 433(4):420-5. PubMed ID: 23523798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]